Champions Oncology (CSBR) Profit After Tax Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
33.21% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
30.60% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-154.28% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
16.53% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Champions Oncology |
81.79 Mn |
74.79 Mn |
13.89 Mn |
51.46% |
| Date | Value |
|---|
| Jan 31, 2026 |
51.46% |
| Oct 31, 2025 |
165.66% |
| Jul 31, 2025 |
-13.47% |
| Apr 30, 2025 |
-74.76% |
| Jan 31, 2025 |
78.75% |
| Oct 31, 2024 |
38.00% |
| Jul 31, 2024 |
112.78% |
| Apr 30, 2024 |
45.49% |
| Jan 31, 2024 |
-66.77% |
| Oct 31, 2023 |
-1,175.07% |
| Jul 31, 2023 |
-230.84% |
| Apr 30, 2023 |
-5.76% |
| Jan 31, 2023 |
-225.60% |
| Oct 31, 2022 |
-27.08% |
| Jul 31, 2022 |
20.75% |
| Apr 30, 2022 |
-10.78% |
| Jan 31, 2022 |
60.48% |
| Oct 31, 2021 |
1.23% |
| Jul 31, 2021 |
-33.07% |
| Apr 30, 2021 |
-2.12% |
